Type 2 Diabetes: Understanding its Early Drivers and the Road to Therapeutics
Type 2 Diabetes: Understanding its Early Drivers and the Road to Therapeutics
批准号:
10682747
负责人:
TERRY L. SHEPPARD
金额:
$1.32万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
已结题
起止时间:
2023-04-05 至 2024-03-31
关键词:
AbateAddressAffectBasic ScienceBeta CellCareer MobilityClassificationCollaborationsCommunicationComplications of Diabetes MellitusDevelopmentDiabetes MellitusDiagnosisDiseaseEarly DiagnosisEducationEducational workshopEventFailureFutureGlucoseGlycosylated hemoglobin AGrowthHomeostasisIndustrializationInsulin ResistanceInterventionKnowledgeLearningLegal patentLifeMeasuresMetabolicMetabolic DiseasesMethodologyMolecularNon-Insulin-Dependent Diabetes MellitusObesityOrganOutcomeParticipantPathogenesisPathway interactionsPatientsResearchResearch PersonnelRetinal DiseasesScientistStructure of beta Cell of isletTechnologyTherapeuticThinkingTimeTranslational ResearchTreatment outcomeVisionWorkcareerclinical practicecomorbiditydesigndiabetes mellitus therapydiabetes pathogenesisimprovedinsightinterestmortalitymultidisciplinarynext generationnoveloff-patentpostersprecision medicinepreventsymposiumtherapeutically effectivetreatment and outcome
中文摘要
摘要
英文摘要
ABSTRACT
Support is requested for a Keystone Symposia conference entitled Type 2 Diabetes: Understanding its Early
Drivers and the Road to Therapeutics, organized by Drs. Christopher Rhodes, Lora Heisler, and Martin Myers.
The conference will be held in Palm Springs, CA from May 1 - 4, 2023.
Early detection and consequential intervention are key to good treatment outcomes and avoidance of
complications for most diseases. Arguably, this may not be the case for Type-2 diabetes (T2D) where
measures of elevated glucose and HbA1C, historically related to a predicted onset of retinopathy, occur too
late in the pathogenesis of the disease. This makes the need for improved markers of T2D necessary to
better diagnose and treat this prevalent disease at early stages. With the advent of precision medicine, now is
the time to re-examine the pathogenesis of type 2 (pre)diabetes at the molecular level. However, questions
the field remain, such as: 1. Which subsets of T2D define the rate of progression to certain diabetes
complications; 2. Can early molecular drivers of the disease be better identified; 3. What factors contribute to
dysfunctional inter-organ communication and altered metabolic homeostasis; 4. Does pancreatic ß-cell failure
really define the disease; and 5. If detected early enough, can we envision ways to reverse, or even prevent
T2D? The silver lining is that with several commonly used T2D therapies coming off patent soon, this may just
be conceivable. Nonetheless, there also remains a need for more effective therapeutic approaches, not just
for T2D, but also for its comorbidities. Therefore, this Keystone Symposia conference will examine the current
knowledge of T2D pathogenesis and the therapeutic landscape with a vision towards earlier diagnosis, as well
as, towards more effective and tailored T2D treatment regime(s) that could also prevent (or significantly delay)
the pathway to complications and comorbidities.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Pulmonary Hypertension: State of the Art and Therapeutic Opportunities
-
批准号:10682118
-
项目类别:
-
资助金额:$1.53万
-
财政年份:2023
-
负责人:TERRY L. SHEPPARD
-
依托单位:
Infections in Pregnancy: PathogenicMechanisms, Experimental Advances and Clinical Strategies
-
批准号:10540260
-
项目类别:
-
资助金额:$1.0万
-
财政年份:2023
-
负责人:TERRY L. SHEPPARD
-
依托单位:
Mechanisms of Microbiota-Immune Interactions-Towards the Next Decade
-
批准号:10753451
-
项目类别:
-
资助金额:$0.6万
-
财政年份:2023
-
负责人:TERRY L. SHEPPARD
-
依托单位:
Vaccinology During and After COVID-19
-
批准号:10753782
-
项目类别:
-
资助金额:$0.75万
-
财政年份:2023
-
负责人:TERRY L. SHEPPARD
-
依托单位:
Transposable Elements at the Crossroads of Evolution, Health and Disease
-
批准号:10750852
-
项目类别:
-
资助金额:$1.5万
-
财政年份:2023
-
负责人:TERRY L. SHEPPARD
-
依托单位:
Long COVID and Post Acute Sequalae of SARS CoV 2 (PASC): Pathogenesis and Treatment
-
批准号:10749522
-
项目类别:
-
资助金额:$2.13万
-
财政年份:2023
-
负责人:TERRY L. SHEPPARD
-
依托单位:
B Cell Biology in the Context of Infectious Diseases, Autoimmunity and B Cell Cancers
-
批准号:10683443
-
项目类别:
-
资助金额:$1.5万
-
财政年份:2023
-
负责人:TERRY L. SHEPPARD
-
依托单位:
Metastasis
-
批准号:10681132
-
项目类别:
-
资助金额:$1.5万
-
财政年份:2023
-
负责人:TERRY L. SHEPPARD
-
依托单位:
Inflammation in the Lung: Friend or Foe in Viral Infections?
-
批准号:10681956
-
项目类别:
-
资助金额:$1.5万
-
财政年份:2023
-
负责人:TERRY L. SHEPPARD
-
依托单位:
HIV Vaccines, Immunoprophylaxis and Drugs
-
批准号:10699245
-
项目类别:
-
资助金额:$2.13万
-
财政年份:2023
-
负责人:TERRY L. SHEPPARD
-
依托单位:
B Cells and Tertiary Lymphoid Structures: Emerging Targets in Cancer Therapeutics
-
批准号:10754008
-
项目类别:
-
资助金额:$0.6万
-
财政年份:2023
-
负责人:TERRY L. SHEPPARD
-
依托单位:
Myeloid Cell Diversity: From Fundamental Biology to Disease States
-
批准号:10753412
-
项目类别:
-
资助金额:$1.25万
-
财政年份:2023
-
负责人:TERRY L. SHEPPARD
-
依托单位:
RNA Modifications in Health and Disease
-
批准号:10754076
-
项目类别:
-
资助金额:$0.75万
-
财政年份:2023
-
负责人:TERRY L. SHEPPARD
-
依托单位:
Emerging Cellular Therapies at the Forefront of Cancer Immunotherapy
-
批准号:10540496
-
项目类别:
-
资助金额:$1.1万
-
财政年份:2023
-
负责人:TERRY L. SHEPPARD
-
依托单位:
From First Breath: Lung Development, Infection, Repair and Aging
-
批准号:10678811
-
项目类别:
-
资助金额:$1.65万
-
财政年份:2023
-
负责人:TERRY L. SHEPPARD
-
依托单位:
Precision Genome Engineering
-
批准号:10608865
-
项目类别:
-
资助金额:$2.1万
-
财政年份:2023
-
负责人:TERRY L. SHEPPARD
-
依托单位:
T and B Cell Collaboration in Germinal Centers and Beyond
-
批准号:10753621
-
项目类别:
-
资助金额:$0.55万
-
财政年份:2023
-
负责人:TERRY L. SHEPPARD
-
依托单位:
Metabolic and Molecular Mechanisms of NAFLD/NASH
-
批准号:10682156
-
项目类别:
-
资助金额:$1.92万
-
财政年份:2023
-
负责人:TERRY L. SHEPPARD
-
依托单位:
Heart Development and Disease: From Genes to Cures
-
批准号:10608624
-
项目类别:
-
资助金额:$1.62万
-
财政年份:2023
-
负责人:TERRY L. SHEPPARD
-
依托单位:
Signals and Mechanisms Underlying the Benefits of Exercise
-
批准号:10750822
-
项目类别:
-
资助金额:$1.89万
-
财政年份:2023
-
负责人:TERRY L. SHEPPARD
-
依托单位:
海外基金